Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Resveratrol longevity trials in 2026 are predominantly doctor-led, with qualified physicians overseeing safety and efficacy; you can locate them by searching ClinicalTrials.gov, university medical center research pages, PubMed listings and professional association directories below. These interventional studies are largely in phases I and II, targeting optimal dosing and early aging biomarkers.
Eligibility criteria, informed consent details, visit schedules and safety monitoring can all impact which trial is right for you; see complete information below.
Interest in resveratrol and longevity clinical trials is growing as researchers explore whether this natural compound—found in red wine, grapes and berries—can support healthy aging in humans. If you're curious about joining a study led by qualified physicians, here's a clear, step-by-step guide to finding and evaluating doctor-led resveratrol trials in 2026.
Resveratrol has shown promising anti-aging effects in laboratory models, including:
However, results in animals don't always translate directly to people. That's why doctor-led clinical trials—where medical experts design, oversee and analyze the research—are essential. They help ensure safety, accuracy and reproducibility of findings about resveratrol's impact on human aging.
A doctor-led trial means:
These trials typically progress through phases:
Most resveratrol longevity research remains in phases I and II, focusing on safety, optimal doses and early biomarkers of cellular aging.
This U.S. government registry lists thousands of ongoing studies worldwide.
Leading research institutions often host trials before they're widely publicized.
Published trial protocols and results can lead you to ongoing or upcoming studies.
Organizations focused on aging, gerontology or nutritional science often list member-led trials.
Visit their websites or contact membership offices for trial directories.
Academic and industry conferences showcase cutting-edge research.
Specialized platforms connect volunteers with studies that match their profile.
When evaluating any resveratrol and longevity clinical trial, keep these points in mind:
Eligibility Criteria
Informed Consent
Trial Location and Schedule
Safety Monitoring
Compensation and Costs
If you're experiencing new or worsening health issues, it's always wise to seek guidance. Before scheduling an appointment with your doctor, you can quickly assess your symptoms using a Medically approved LLM Symptom Checker Chat Bot to help organize your concerns and determine the urgency of care needed.
Remember: never delay seeking immediate care for chest pain, sudden shortness of breath, signs of stroke, severe bleeding or other life-threatening symptoms. Always speak to a physician if you're in doubt about your condition.
By following these steps, you'll be well-positioned to find and join a reputable, doctor-led resveratrol and longevity clinical trial in 2026. Contributing to human aging research not only benefits you by granting early access to new interventions but also helps the medical community unlock better strategies for healthy living in later years.
(References)
* Dyck GJB, Raj P, Zieroth S, Netticadan T, Dixon IMC. Resveratrol: The Therapeutic Potential of a Promising Molecule: A Review of Human Clinical Trials. Mol Nutr Food Res. 2017 Jul;61(7).
* Hosseini S, Saedisomeolia A, Ghavamzadeh M. The Clinical Effects of Resveratrol Supplementation on Metabolic Syndrome: A Systematic Review and Meta-Analysis. Phytother Res. 2019 Jun;33(6):1549-1563.
* Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al. Resveratrol: A Critical Review of the Literature for its Potential Therapeutic Efficacy and Safety. Phytother Res. 2020 Jan;34(1):5-29.
* Kordestani-Moghadam F, Ghaedi E, Shahmohammadi M, Mirghafourvand M, Bahadori B, Varkaneh HK. Effects of Resveratrol Supplementation on Inflammatory Markers: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Phytother Res. 2021 Jan;35(1):15-32.
* Zhang H, Zhang J, Li X, Wei X, Ma Y, Chen Y. Clinical Trials on Resveratrol for Cardiovascular Diseases: A Systematic Review. Clin Nutr. 2018 Apr;37(2):427-434.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.